Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. - Wikidata - awgldk - TriplyDB

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

http://www.wikidata.org/entity/Q53659259

about

Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Decoding the usefulness of non-coding RNAs as breast cancer markers Circulating microRNAs: potential biomarkers for common malignancies Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Dampening enthusiasm for circulating microRNA in breast cancer.Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro Regulation of cancer metastasis by cell-free miRNAs.High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.Analysis of miRNA expression profiles in breast cancer using biclustering.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4 Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients.MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer Noncoding RNAs in breast cancer.Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions.Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma MiRNAs which target CD3 subunits could be potential biomarkers for cancers.Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.Circulating nucleic acids as biomarkers in breast cancer.Hide and seek: tell-tale signs of breast cancer lurking in the blood.An emerging role for microRNAs in NF1 tumorigenesis.microRNAs: a new class of breast cancer biomarkers.miR-214: a potential biomarker and therapeutic for different cancers.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.Noncoding RNAs in Cancer Diagnosis.Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.MiRNAs-mediated cisplatin resistance in breast cancer.

P2860

Q26772219-ED763B6A-5F2D-4100-AD58-A8D9DF357D09 Q26775086-55FF3D4E-207F-4306-8F29-B301107BF5C5 Q26825022-71928AB3-EF27-4F78-A96E-C06FFBEB984F Q28069370-F1FAC172-5612-4ED0-8680-212E6DE29A2E Q28081347-416B0020-D022-4BE6-8932-E15008D2B083 Q28539562-79E93924-119C-4D77-A353-A63BB46C071D Q33720085-3041E99E-A20F-4B6E-9684-3CEE84081608 Q33751048-DDDAF7E2-4664-460D-9B04-53E519E21ADB Q34221705-39147495-551C-43B6-A847-98A14CBAB542 Q34391443-9A5EAE81-6970-4453-A7DD-19FAE88FB47E Q34426839-286B1B37-460D-4CC5-97C5-B1D3B2934A35 Q34614489-98EF102D-DAD5-4A79-9CDE-225729902FA3 Q35010133-6E2E1447-743C-4498-80C8-FECC50DBCF6B Q35034340-2FA5A808-892A-4EA2-9EC4-4AB4A8C8BE48 Q35105646-8BB9C58A-C066-4B51-A767-78326C886CD1 Q35141171-7F685D60-139D-4CF3-A016-C263F1BA3A39 Q35203556-2BB2D161-F19A-4857-9B80-AB8044F2DB2F Q35221535-49CFE004-29FE-4816-ADF4-624444979002 Q35402769-ED5DF16A-80BC-45BD-8ACE-D4B3E76F8E68 Q36251395-8F35E36B-8EF4-449F-9825-E1E9C56B031B Q36336233-47D6B679-6A87-4F38-A94C-60681FD40531 Q36370545-9BAAF1B7-7119-4C0B-9FCE-BC03F4EF0C3E Q36546638-84DF809A-59A0-4C64-96A2-E45082D15C8E Q36935047-BD2FB48A-680E-4738-8CB6-EF4DECAE4226 Q37195490-804E2E4F-7680-41D9-BCF8-EF5B89081748 Q37196131-A2479A75-D80B-458F-81FE-AAA37FCF3592 Q37297742-51465780-0AB1-4078-B9BA-16A10A8DFC8B Q37551941-2FC701A7-0FF5-4822-9168-63BE0F54CAD3 Q37564492-77DCB501-2387-4193-8B7B-5A8BF790996B Q37690204-58AADC40-4DC3-4A27-8C15-E9FD3C0B31CC Q38056383-89933649-6666-4EBF-A8A5-D9AD81FDC5F1 Q38060281-A2DD57FA-EB16-451A-BE28-CC42562109C9 Q38197675-ED8F8453-5D09-4526-A29D-4A440C315BEA Q38319595-4449C23D-AAE2-4113-A883-8DC14536A2F8 Q38336073-A97AE01A-8E19-441C-BB0F-B4DEABFABE3E Q38731400-55E941A7-6622-4727-8AC0-3750E43D5075 Q38874857-E7078121-F730-4A6D-B29A-504A899535E2 Q38885507-E5FC1DA3-237A-4719-B982-D0357BE5BF06 Q38886081-7EBB3E4D-E131-4A07-8F6D-2155C16FDB72 Q38905681-046410F0-DF11-4193-B484-9DF9EB0A989C

P2860

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

http://www.wikidata.org/entity/Q53659259

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@en

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@nl

type

label

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@en

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@nl

prefLabel

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@en

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@nl

P1433

Q53659259-FD762A9A-AA38-42DD-9031-54701B61A2AF

P1476

Q53659259-9A19F45B-CA22-4445-A362-1E5A22CACEBD

P2093

Q53659259-1155D7F2-B3ED-4D93-813E-FA74CB53C8F7

Q53659259-61C2DB84-FDC9-4560-9835-E13071793418

Q53659259-702F24AC-EBFE-44F4-BD1C-60824962BA8F

Q53659259-811800A0-9EF4-4A70-873A-8F349E1CC374

Q53659259-ED0D9057-2A5E-47AA-9D33-7FD3CB1CF1DE

P2860

Q53659259-06A412DD-19B4-47B3-8224-EC9CF697B172

Q53659259-0D35AC1E-6111-4FF0-A936-F755B4D48FFD

Q53659259-0F619FF2-3D94-4E57-B84A-8BE5A95880B0

Q53659259-1024FFDE-F71F-400F-B62D-E79246D55317

Q53659259-14048FD1-B605-45F4-8497-4903BF70E647

Q53659259-179A8E69-C28F-4D43-BEEC-3EC2A8CE69DD

Q53659259-3111CD99-2492-4845-B196-8C10BF73A407

Q53659259-31BCC404-A705-4601-9916-1DC5F3AB115C

Q53659259-34451A84-123C-40DE-85B5-A31738D057AD

Q53659259-3F0D8143-7956-41DC-A8DE-CE3482A3358D

P2888

Q53659259-B2696B41-C4DE-416E-9B99-C1D37D654DE5

P304

Q53659259-2D1F82F7-E883-424B-BD5B-BDA015D2B560

P31

Q53659259-4CD0D4D0-4D86-4A5B-A835-74EA488DE149

P356

Q53659259-99685ED7-58A8-473A-B9D5-868968279AF0

P407

Q53659259-8B9BD61B-70DB-40DA-AA0F-12F3FF8BDBDC

P433

Q53659259-A410A7A4-3534-4009-AA85-F6E5F6594F06

P478

Q53659259-989F56DB-D27C-4F15-9812-65D9A12BD70A

P577

Q53659259-05811D0A-B13B-4FD7-AA35-1CBAF5302C77

P5875

Q53659259-062760A1-A17C-4CD1-B774-41B82D3597C9

P698

Q53659259-6B2C13AA-7B30-4703-BCDF-587D9DECB414

P921

Q53659259-C25299FB-60AF-4338-AEF4-08493C4692AD

P356

S10549-012-1988-6

P1433

Breast Cancer Research and Treatment

P1476

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

@en

P2093

Bettina Steinbach

http://www.w3.org/2001/XMLSchema#string

Heidi Schwarzenbach

http://www.w3.org/2001/XMLSchema#string

Karin Milde-Langosch

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Volkmar Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

Prediction of mammalian microRNA targets

Oncomirs - microRNAs with a role in cancer

The diverse functions of microRNAs in animal development and disease

mir-17-92, a cluster of miRNAs in the midst of the cancer network

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

Dicer is essential for mouse development

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

P2888

s10549-012-1988-6

P304

933-941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-012-1988-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221848064

http://www.w3.org/2001/XMLSchema#string

P698

22350790

http://www.w3.org/2001/XMLSchema#string

P921